Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.6050 (-1.67%) ($5.4260 - $5.6970) on Wed. Aug. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.42% (three month average) | RSI | 32 | Latest Price | $5.6050(-1.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(29%) TIP(22%) CEMB(18%) LQD(9%) ARKG(8%) | Factors Impacting CAPR price | CAPR will decline at least -4.21% in a week (0% probabilities). URA(-36%) XLB(-33%) PAVE(-27%) XOP(-24%) OIH(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.21% (StdDev 8.42%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-22.72(-505.35%) | Resistance Level | $6.61 | 5 Day Moving Average | $5.76(-2.69%) | 10 Day Moving Average | $6.03(-7.05%) | 20 Day Moving Average | $6.61(-15.2%) | To recent high | -42.9% | To recent low | 11.9% | Market Cap | $110m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |